Vanguard Group Inc Surmodics Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Surmodics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 803,296 shares of SRDX stock, worth $27.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
803,296
Previous 803,508
0.03%
Holding current value
$27.6 Million
Previous $31.2 Million
2.09%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SRDX
# of Institutions
141Shares Held
12MCall Options Held
31.4KPut Options Held
13.2K-
Black Rock Inc. New York, NY1.17MShares$40.3 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.01MShares$34.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY675KShares$23.2 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X0454KShares$15.6 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT394KShares$13.5 Million1.09% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $481M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...